bioAffinity Technologies, Inc. (BIAF) — Financial Flexibility Index
bioAffinity Technologies, Inc. (BIAF) has a Financial Flexibility Index of -0.68x as of December 2025. Free cash flow of $-2.50 Million (operating CF $-2.56 Million minus capex $60.56K) represents -1% of total liabilities ($3.68 Million). Check BIAF goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
bioAffinity Technologies, Inc. Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for bioAffinity Technologies, Inc. across 7 annual periods. For the full cash flow conversion analysis, see BIAF operating cash flow.
Annual Financial Flexibility Index for bioAffinity Technologies, Inc. (2019–2025)
Year-by-year free cash flow to debt coverage for bioAffinity Technologies, Inc.. Explore bioAffinity Technologies, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.52x | $-9.27 Million | $-9.33 Million | $3.68 Million | ▼ -37.0% |
| 2024 | -1.84x | $-7.19 Million | $-7.26 Million | $3.91 Million | ▼ -2.8% |
| 2023 | -1.79x | $-6.01 Million | $-6.04 Million | $3.37 Million | ▲ +47.2% |
| 2022 | -3.38x | $-3.85 Million | $-4.07 Million | $1.14 Million | ▼ -2746.1% |
| 2021 | -0.12x | $-2.05 Million | $-2.05 Million | $17.24 Million | ▲ +18.0% |
| 2020 | -0.14x | $-2.20 Million | $-2.21 Million | $15.22 Million | ▲ +72.6% |
| 2019 | -0.53x | $-2.48 Million | $-2.49 Million | $4.69 Million | — |